Washington, DC 20006-5349
HELPLINE
Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY…
The Meso Foundation congratulates Dr. Harvey Pass for receiving the Merit Award from the International Association for the Study of Lung Cancer (IASLC). Dr. Pass…
We have big news and need your help! Today, the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’ was introduced in Congress by Congressional…
In his most recent State of the Union address, President Obama announced a bold new research effort to revolutionize how we improve health and treat…
A Phase 3 French study, which will be presented at the American Society of Clinical Oncology (ASCO)’s annual meeting at the end of May, demonstrated…
by Melinda Kotzian, Chief Executive Officer, Mesothelioma Applied Research Foundation Over the last 24 hours, news broke that some cancer charities raised funds and did…
The Meso Foundation is optimistic about the results of the Phase 1b trial of pembrolizumab for PD-L1-positive advanced solid tumors, which were announced at the…
Marjorie Zauderer, MD, is a medical oncologist at Memorial Sloan Kettering Cancer Center specializing in the care of lung cancer and mesothelioma patients, and serves…
Richard M. Schulze is the founder and chairman emeritus of Best Buy Co., Inc., the world’s largest multi-channel, consumer-electronic retailer. His connection to mesothelioma is…
***The Best of iMig 2014 updates were created by iMig and distributed to conference attendees during iMig 2014. The following is a verbatim re-post of…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
